http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20141823-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2013-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0785623b9ad88b2704cf23c67795cb77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eac882e27f0f0e850ad2d25aecd8421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa724e24363c73cfdd312154837e1ddc
publicationDate 2014-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20141823-A1
titleOfInvention TETRAHYDRO-QUINAZOLINONE DERIVATIVES
abstract REFERS TO A COMPOUND OF FORMULA I, WHERE: U IS CH2 OR CHR2; V IS CH2, CHR2, OR CO; W IS NR1 OR CR3R6; R1 IS AR, HET, COA, AMONG OTHERS; R2 IS A, AR1, HAL, CN, AMONG OTHERS; R3 IS H, OH, AMONG OTHERS; R6 IS A OR AR1; AR IS PHENYLUS, HAL, A, AMONG OTHERS; AR1 IS PHENYL, HAL, A, (CH2) MOH, AMONG OTHERS; HET IS HETEROCICLIC OPTIONALLY SUBSTITUTED WITH 1 TO 4 ATOMS OF N, O AND / OR S; A IS C1-C10 ALKYL; HAL IS F, CL, BR O I; M IS 0-4. PREFERRED COMPOUNDS ARE: 2- [4- (4-METHOXY-PHENYL) -PIPERAZIN-1-IL] 5,6,7,8-TETRAHYDRO-3H-QUINAZOLIN-4-ONA; 2- [4- (3-FLUOROPHENYL) PIPERAZIN-1-IL] -5,6,7,8-TETRAHYDRO-3H-QUINAZOLIN-4-ONA; AMONG OTHERS. SAID COMPOUND IS AN INHIBITOR OF TANKIRASE, USEFUL IN THE TREATMENT OF CANCER.
priorityDate 2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20494721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422800739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421926694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124254946

Total number of triples: 35.